Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Originally published on October 13, 2022, this episode features Luis in conversation with Dr. Paul Hergenrother from the University of Illinois. Dr. Hergenrother discusses Fabimycin, an antibiotic candidate targeting gram-negative bacteria. What is Fabimycin's mechanism of action? Which bacteria is it active against? Is there any intrinsic resistance? Tune in to find out!
Link to article: https://pubs.acs.org/doi/10.1021/acscentsci.2c00598
Questions? Feedback? Send those to [email protected]
Want to support the podcast? Here's how:
Venmo: https://venmo.com/u/letstalkmicro
Buy me a Ko-fi: https://ko-fi.com/letstalkmicro